IT vs RLMD · P/E 16, rev $6.27B vs $692.3M cap
Gartner Inc (IT) versus Relmada Therapeutics Inc (RLMD) — a side-by-side from cached financials, not a winner call.
Gartner Inc (IT) is a information technology services company listed on US.
Relmada Therapeutics Inc (RLMD) is a biotechnology company listed on NASDAQ.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
RLMD does not have a complete income-statement cache yet.
IT currently screens at market cap $11.03B and trailing P/E 16.3. RLMD currently screens at market cap $692.3M.
Not investment advice. Open the IT and RLMD stock pages for the full models.
Not investment advice.